Taking the journey towards comprehensive treatment of liver disease  

An emerging global leader in the development of molecularly-targeted drugs and combination therapies to treat liver diseases and liver cancer.

 
terns-final-homepage.jpg

OUR VISION

We are developing a pipeline of novel molecularly-targeted drugs and combination therapies for the treatment of chronic liver diseases such as non-alcoholic steatohepatitis (NASH), fibrosis and hepatocellular carcinoma.

blue-terns.jpg

LIVER DISEASE

Terns is focused on a comprehensive solution to the global problem of liver disease.

We are developing a pipeline of novel therapies that target chronic liver diseases such as non-alcoholic steatohepatitis (NASH), fibrosis and hepatocellular carcinoma.